|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- GBD 2023: High SBP, Diet and High LDL-C Top Drivers of US IHD DeathsNearly 90% of ischemic heart disease (IHD) deaths in 2023 in the U.S. were attributable to modifiable risk factors, led by high systolic blood pressure (SBP), dietary risks and high LDL-C, according to data from the Global Burden of Disease Study 2023 (GBD 2023), published July 15 in JAMA Cardiology.
- IL-6 as a Predictor of CV Risk Assessment: Role of Canakinumab and Ziltivekimab in Preventive CardiologyThe 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia identified low-density lipoprotein cholesterol (LDL-C) as the primary lipoprotein for therapeutic targeting.1 Similarly, lipoprotein(a) [Lp(a)] and high-sensitivity C-reactive protein (hs-CRP) also have long-standing independent associations with the development of atherosclerotic cardiovascular disease (ASCVD).
- Procedure-Related Infective Endocarditis is Rare, Not Associated With Antibiotic Prophylaxis DosingThere was so significant association between antibiotic prophylaxis (ABP) dosing before congenital cardiac catheterization and early infective endocarditis (IE) post procedure, according to a retrospective analysis recently published in JACC: Advances. Overall, IE was rare and largely dependent on procedure type.
- The Importance of Enhanced Radiation Protections in Cath LabsIn this week’s View, Dr. Eagle looks at age, body mass index (BMI), and cardiovascular outcomes after transcatheter aortic valve replacement (TAVR).
- AI-Enabled CCTA Reveals Premature Plaque Burden in South AsiansSouth Asians (SA) in the United States carry a higher burden of atherosclerotic cardiovascular disease (ASCVD) than other ethnic groups, and standard risk prediction tools often fail to capture this elevated risk.



